Global Health Ltd

Global Health Ltd

$MEDANTAHospitalNSEBSE

Global Health Ltd (MEDANTA) last traded at ₹1,409, a market capitalisation of ₹37,885 crore, on a P/E of 66.2. Over the past 52 weeks the stock has ranged between ₹955 and ₹1,491. Global Health Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1,304 crore and net profit of ₹157 crore. The next scheduled event is an analyst meet on 26 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.

Global Health Ltd share price and key metrics

Current price
₹1,409
Market cap
₹37,885 cr
Stock P/E
66.2
Book value
₹147
ROE
15.2%
ROCE
17.4%
Dividend yield
0.04%
52w high / low
1491/955

Metrics as of 25 Aug 2026. Not real time.

Global Health Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹1,304 cr, up 26.5% from ₹1,031 cr a year earlier. Net profit was ₹157 cr, down 1.3% year on year.

Global Health Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9579439311,0311,0991,1211,1591,304
Expenses7287067077848689049151,017
Operating profit228238225247231217244287
OPM %24%25%24%24%21%19%21%22%
Other income1816-272036-153722
Interest1616151417222727
Depreciation4948494550616769
Profit before tax181189133208200120187213
Tax %28%24%24%24%21%21%24%26%
Net profit13114310115915895142157
EPS (₹)4.875.323.785.925.893.545.365.90

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Global Health Ltd annual results

Global Health Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,4472,1672,7103,2753,6924,4104,683
Operating profit197458637809886930979
OPM %14%21%24%25%24%21%21%
Net profit29196326478481554552
EPS (₹)5.817.7512.1617.8117.9220.7020.69

TTM is the trailing twelve months to the most recent quarter.

Global Health Ltd growth and returns

Compounded Sales Growth
10 Years
12%
5 Years
25%
3 Years
18%
TTM
21%
Compounded Profit Growth
10 Years
13%
5 Years
81%
3 Years
19%
TTM
0%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
26%
1 Year
1%
Return on Equity
10 Years
%
5 Years
16%
3 Years
16%
Last Year
15%

Global Health Ltd shareholding pattern

Promoters held 33.00% at Jun 2026, broadly unchanged since Jun 2025. FIIs 9.46% and DIIs 16.89%.

Global Health Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters33.04%33.03%33.03%33.01%33.01%33.01%33.01%33.00%
FIIs12.21%12.48%11.76%11.54%11.41%10.54%10.15%9.46%
DIIs11.11%10.51%11.93%12.20%12.97%13.99%14.76%16.89%
Public43.64%43.98%43.28%43.19%42.56%42.41%42.01%40.55%
No. of shareholders1,49,7221,48,6331,54,6881,56,3721,55,8061,51,2411,47,3901,40,531

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Upcoming Global Health Ltd events

The next scheduled event is an analyst meet on 26 Aug 2026.

  • Analyst meetAnalyst/Institutional Investor Meetings with Motilal Oswal Financial Services
  • Analyst meetAnalyst/Institutional Investors Meeting
  • AGM22nd Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Global Health Ltd corporate filings

  • Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Global Health Ltd has issued a routine intimation regarding a scheduled meeting with…

    Read the full analysis
  • Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…

    Read the full analysis
  • Announcement under SEBI Listing Regulations regarding Schedule of Institutional Investor Meet.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…

    Read the full analysis
  • Post Dispatch Advertisement for the 22nd Annual General Meeting for the Financial Year 2025-26.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Global Health Ltd has completed the mandatory newspaper publication regarding the notice…

    Read the full analysis
  • Enclosed.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Global Health Ltd has provided the weblink to its Annual Report for the financial year…

    Read the full analysis
  • Business Responsibility and Sustainability Report along with Assurance Report for the Financial Year 2025-26.Otherslow impact
    Filing PDF

    Cruxal's analysis: Global Health Ltd has submitted its Business Responsibility and Sustainability Report…

    Read the full analysis
  • Reg. 34 (1) Annual Report.Othershigh impact
    Filing PDF

    Cruxal's analysis: Global Health Limited (Medanta) has released its Annual Report for FY 2025-26…

    Read the full analysis
  • EnclosedAGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Global Health Limited has issued a notice for its 22nd Annual General Meeting (AGM) to be…

    Read the full analysis
  • Announcement under SEBI Listing Regulations regarding Schedule of Analyst Meet.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled analyst and investor…

    Read the full analysis
  • Copy of Pre-advertisement of Annual General Meeting 2026.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Global Health Ltd has published a pre-advertisement notice regarding its upcoming Annual…

    Read the full analysis
  • Announcement under Regulation 30 of Listing Regulations,2015 for Earning Conference call Transcript.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Global Health Limited (Medanta) delivered a robust Q1 FY27 performance, with consolidated…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Global Health Ltd

Cruxal reads every Global Health Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.